A treatment to improve the appearance of a double chin.
Sometimes, no matter how much you diet or exercise, the fullness in this area may not go away – and it may make you feel like you look older and heavier than you actually are.
Fullness under the chin or a ‘double chin’ also known as submental fullness is a common concern for both men and women. It can be caused by:
The active ingredient in Belkyra is synthesised deoxycholic acid. Deoxycholic acid also occurs naturally in the body where it helps to break down dietary fat. When injected below the chin, Belkyra reduces fat, resulting in a more contoured neck profile and jawline. As it is a prescription-only medicine, Belkyra treatment is only available from your clinician.
BELKYRA® is an injectable treatment that improves the appearance of a double chin.
Many people treated with Belkyra experienced visible improvement in the appearance of their chin profile in 2–4 treatments. Up to six treatments may be administered, spaced at least four weeks apart.
Belkyra is typically given in a 15- to 20-minute in-office treatment session. We will administer a series of injections into the area under your chin at each session.
Many patients treated with Belkyra experience visible improvement of their chin profile in 2–4 treatments. Some people require up to six treatments in order to achieve their best results. Once your desired results are achieved, additional treatments may not be needed as results are maintained for at least four years.
As with other injectable treatments, you may experience side effects with Belkyra. Most patients experience mild or moderate pain or discomfort at the time Belkyra is injected.
Prior to administering Belkyra, your clinician may apply ice/cold packs or topical and/or injectable local anaesthesia (e.g. lidocaine) to the treatment area to make you more comfortable. They may also suggest that you take an over-the-counter pain medication before your appointment.
BELKYRA® injection is a prescription medicine containing 10 mg/mL deoxycholic acid. It is used for the improvement in the appearance of moderate to severe convexity or fullness associated with submental fat in adults. Do not use in people allergic to this medicine, with infection at site of injection, pregnancy and lactation. Possible side effects include headaches, difficulty swallowing, nausea, skin tightness, hypertension, injection site bruising/pain/swelling/numbness/redness/tingling/hardness/itching/discolouration/formation of small areas of hardness/warmth and injection site nerve injury. BELKYRA® treatment is not funded on the New Zealand Pharmaceutical Schedule. You will need to pay for this medicine. Normal Doctors visit fees apply. BELKYRA® treatment should be administered only by trained medical professionals. Speak to your specialist about your own situation and about the benefits/risks of this procedure in appearance medicine. For further information, the Data Sheet and Consumer Medicines Information can be accessed at www.medsafe.govt.nz or ask your doctor. If you have any side effects or concerns speak to your doctor. Note: Results from BELKYRA® treatment usually last up to four years.
Please note that individual results may vary from patient to patient, and the information provided on our website is only a guidance to the possible results.